Literature DB >> 11309686

Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.

J Cui1, M P Staples, J L Hopper, D R English, M R McCredie, G G Giles.   

Abstract

Segregation analyses aim to detect genetic factors that have a major effect on an individual's risk of disease and to describe them in terms of mode of inheritance, age-specific cumulative risk (penetrance), and allele frequency. We conducted single- and two-locus segregation analyses of data from 1,476 men with prostate cancer diagnosed at age <70 years and ascertained through population registries in Melbourne, Sydney, and Perth, Australia, and from their brothers, fathers, and both maternal and paternal lineal uncles. Estimation and model selection were based on asymptotic likelihood theory and were performed through use of the software MENDEL. All two-locus models gave better fits than did single-locus models, even if lineal uncles were excluded or if we censored data (age and disease status) for relatives at 1992, when prostate-specific-antigen testing started to have a major impact on the incidence of prostate cancer in Australia. Among the genetic models that we considered, the best-fitting ones included a dominantly inherited increased risk that was greater, in multiplicative terms, at younger ages, as well as a recessively inherited or X-linked increased risk that was greater, in multiplicative terms, at older ages. The recessive and X-linked effects were strongly confounded, and it was not possible to fit them together. Penetrance to age 80 years was approximately 70% (95% confidence interval [CI] 57%-85%) for the dominant effect and virtually 100% for the recessive and X-linked effects. Approximately 1/30 (95% CI 1/80-1/12) men would carry the dominant risk, and 1/140 (95% CI 1/220-1/90) would carry the recessive risk or 1/200 (95% CI 1/380-1/100) would carry the X-linked risk. Within discussed limitations, these analyses confirm the genetic heterogeneity, of prostate cancer susceptibility, that is becoming evident from linkage analyses, and they may aid future efforts in gene discovery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309686      PMCID: PMC1226101          DOI: 10.1086/320114

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

1.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Authors:  J Cui; A C Antoniou; G S Dite; M C Southey; D J Venter; D F Easton; G G Giles; M R McCredie; J L Hopper
Journal:  Am J Hum Genet       Date:  2000-12-27       Impact factor: 11.025

2.  Familial patterns of covariation for cardiovascular risk factors in adults: The Victorian Family Heart Study.

Authors:  S B Harrap; M Stebbing; J L Hopper; H N Hoang; G G Giles
Journal:  Am J Epidemiol       Date:  2000-10-15       Impact factor: 4.897

3.  An investigation of the familial aspects of carcinoma of the prostate.

Authors:  C M WOOLF
Journal:  Cancer       Date:  1960 Jul-Aug       Impact factor: 6.860

4.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

5.  Segregation and linkage analysis of nine Utah breast cancer pedigrees.

Authors:  D T Bishop; L Cannon-Albright; T McLellan; E J Gardner; M H Skolnick
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

6.  Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study.

Authors:  J Cui; J L Hopper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-08       Impact factor: 4.254

7.  Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.

Authors:  J Xu
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

8.  Association of HPC2/ELAC2 genotypes and prostate cancer.

Authors:  T R Rebbeck; A H Walker; C Zeigler-Johnson; S Weisburg; A M Martin; K L Nathanson; A J Wein; S B Malkowicz
Journal:  Am J Hum Genet       Date:  2000-09-12       Impact factor: 11.025

9.  Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.

Authors:  P L Paris; J S Witte; P A Kupelian; H Levin; E A Klein; W J Catalona; G Casey
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

Review 10.  Genetics of prostate cancer: too many loci, too few genes.

Authors:  E A Ostrander; J L Stanford
Journal:  Am J Hum Genet       Date:  2000-11-07       Impact factor: 11.043

View more
  18 in total

1.  Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Authors:  Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth Gillanders; Suzanne Kolb; Katherine E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.

Authors:  J D McKay; D Thompson; F Lesueur; K Stankov; A Pastore; C Watfah; S Strolz; G Riccabona; R Moncayo; G Romeo; D E Goldgar
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

3.  Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.

Authors:  Bao-Li Chang; Ethan M Lange; Latchezar Dimitrov; Christopher J Valis; Elizabeth M Gillanders; Leslie A Lange; Kathleen E Wiley; Sarah D Isaacs; Fredrik Wiklund; Agnes Baffoe-Bonnie; Carl D Langefeld; S Lilly Zheng; Mika P Matikainen; Tarja Ikonen; Henna Fredriksson; Teuvo Tammela; Patrick C Walsh; Joan E Bailey-Wilson; Johanna Schleutker; Henrik Gronberg; Kathleen A Cooney; William B Isaacs; Edward Suh; Jeffrey M Trent; Jianfeng Xu
Journal:  Hum Genet       Date:  2005-11-23       Impact factor: 4.132

4.  Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.

Authors:  Sanna Pakkanen; Agnes B Baffoe-Bonnie; Mika P Matikainen; Pasi A Koivisto; Teuvo L J Tammela; Snehal Deshmukh; Liang Ou; Joan E Bailey-Wilson; Johanna Schleutker
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

5.  Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.

Authors:  Marc Tischkowitz; Nelly Sabbaghian; Anna M Ray; Ethan M Lange; William D Foulkes; Kathleen A Cooney
Journal:  Prostate       Date:  2008-05-01       Impact factor: 4.104

Review 6.  Prostate cancer susceptibility loci: finding the genes.

Authors:  Elanie A Ostrander; Bo Johannesson
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12.

Authors:  Ethan M Lange; Lindsey A Ho; Jennifer L Beebe-Dimmer; Yunfei Wang; Elizabeth M Gillanders; Jeffrey M Trent; Leslie A Lange; David P Wood; Kathleen A Cooney
Journal:  Hum Genet       Date:  2006-03-01       Impact factor: 4.132

Review 8.  Genetic susceptibility to prostate cancer: a review.

Authors:  Bas A J Verhage; Lambertus A L M Kiemeney
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

9.  Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.

Authors:  Marc D Tischkowitz; Ahmet Yilmaz; Long Q Chen; Danielle M Karyadi; David Novak; Tomas Kirchhoff; Nancy Hamel; Sean V Tavtigian; Suzanne Kolb; Tarek A Bismar; Raquel Aloyz; Peter S Nelson; Lee Hood; Steven A Narod; Kirsten A White; Elaine A Ostrander; William B Isaacs; Kenneth Offit; Kathleen A Cooney; Janet L Stanford; William D Foulkes
Journal:  Cancer Lett       Date:  2008-06-20       Impact factor: 8.679

10.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.

Authors:  Bo Johanneson; Shannon K McDonnell; Danielle M Karyadi; Scott J Hebbring; Liang Wang; Kerry Deutsch; Laura McIntosh; Erika M Kwon; Miia Suuriniemi; Janet L Stanford; Daniel J Schaid; Elaine A Ostrander; Stephen N Thibodeau
Journal:  Hum Genet       Date:  2007-12-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.